- Home
- RVPH vs SHOT Comparison
RVPH vs SHOT Comparison
Compare RVPH & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SHOT
- Stock Information
- Founded
- RVPH 2006
- SHOT 2018
- Country
- RVPH United States
- SHOT United States
- Employees
- RVPH N/A
- SHOT N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SHOT Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- SHOT Health Care
- Exchange
- RVPH Nasdaq
- SHOT Nasdaq
- Market Cap
- RVPH 50.0M
- SHOT 44.2M
- IPO Year
- RVPH N/A
- SHOT 2020
- Fundamental
- Price
- RVPH $1.78
- SHOT $0.76
- Analyst Decision
- RVPH Strong Buy
- SHOT
- Analyst Count
- RVPH 4
- SHOT 0
- Target Price
- RVPH $15.33
- SHOT N/A
- AVG Volume (30 Days)
- RVPH 5.1M
- SHOT 849.0K
- Earning Date
- RVPH 11-14-2024
- SHOT 11-14-2024
- Dividend Yield
- RVPH N/A
- SHOT N/A
- EPS Growth
- RVPH N/A
- SHOT N/A
- EPS
- RVPH N/A
- SHOT N/A
- Revenue
- RVPH N/A
- SHOT $652,495.00
- Revenue This Year
- RVPH N/A
- SHOT N/A
- Revenue Next Year
- RVPH N/A
- SHOT N/A
- P/E Ratio
- RVPH N/A
- SHOT N/A
- Revenue Growth
- RVPH N/A
- SHOT 68.01
- 52 Week Low
- RVPH $0.60
- SHOT $0.55
- 52 Week High
- RVPH $5.67
- SHOT $4.22
- Technical
- Relative Strength Index (RSI)
- RVPH 53.02
- SHOT 38.29
- Support Level
- RVPH $1.23
- SHOT $0.67
- Resistance Level
- RVPH $1.75
- SHOT $1.03
- Average True Range (ATR)
- RVPH 0.53
- SHOT 0.09
- MACD
- RVPH -0.07
- SHOT -0.01
- Stochastic Oscillator
- RVPH 18.57
- SHOT 21.50
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.